Kindeva Drug Delivery

Kindeva Drug Delivery is a global contract development and manufacturing organisation (CDMO) specialising in drug-device combination products. With a legacy of innovation dating back to 1956, Kindeva offers comprehensive solutions from product development through to commercial manufacturing, serving pharmaceutical and biotechnology sectors worldwide.

Kindeva's expertise encompasses a wide range of drug delivery technologies, including inhalation, transdermal, microneedle, and injectable systems. Their integrated approach ensures flexibility and efficiency, enabling partners to bring therapies to market swiftly and safely.

Key Products and Services:

• Aseptic Fill-Finish: State-of-the-art facilities for sterile injectable products, ensuring high-quality and compliant manufacturing processes.
• Pulmonary Delivery: Development and manufacturing of respiratory delivery products, including pressurised metered-dose inhalers (pMDIs).
• Nasal Delivery: Integrated support for nasal drug delivery products, with proven platforms for unit-dose and bi-dose applications.
• Injectable Delivery: Customised drug-delivery options, including autoinjectors and microneedle technologies, for both commercial and governmental partners.
• Intradermal and Transdermal Delivery: Leading capabilities in microneedle array patches and transdermal therapies, offering full-service cGMP CDMO capabilities.

With a commitment to quality and innovation, Kindeva operates multiple manufacturing and R&D facilities across the United States and the United Kingdom. Their team of industry experts collaborates closely with clients to navigate regulatory requirements and deliver high-quality products that improve patient outcomes globally